Hot Penny Stocks: DYAX Sets New 52-Week High Friday

Shares of Nasdaq listed penny stock of Dyax Corp. (DYAX) have gained 17.74% since announcing plans to discontinue Ecallantide phase II trials. A week after that announcement, Needham & Company initiated coverage on DYAX setting a “buy” rating and a $3.50 price target on the makers of KALBITOR®. The coverage was initiated based on the Company’s development pipeline with their four ...

Continue Reading →
0